CN110876707A - Astaxanthin essence extract freeze-dried powder and preparation method thereof - Google Patents
Astaxanthin essence extract freeze-dried powder and preparation method thereof Download PDFInfo
- Publication number
- CN110876707A CN110876707A CN201911255525.9A CN201911255525A CN110876707A CN 110876707 A CN110876707 A CN 110876707A CN 201911255525 A CN201911255525 A CN 201911255525A CN 110876707 A CN110876707 A CN 110876707A
- Authority
- CN
- China
- Prior art keywords
- percent
- astaxanthin
- transparent
- preparation
- freeze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses astaxanthin essence extract freeze-dried powder which comprises the following components in percentage by mass: 4 to 5 percent of mannitol, 3 to 4 percent of trehalose, 1.5 to 2.5 percent of astaxanthin, 0.5 to 1.5 percent of glycerol, 0.03 to 0.07 percent of adenosine, 81.5 to 2.5 percent of acetyl hexapeptide, 0.01 to 0.05 percent of fullerene, 0.03 to 0.07 percent of xanthan gum, 0.03 to 0.07 percent of carnosine, 0.5 to 1.5 percent of hyaluronic acid and 85 to 86 percent of water, wherein the preparation method comprises the following steps: s1, weighing sodium hyaluronate, mannitol and water, stirring and heating to obtain a transparent preparation I; s2, cooling the transparent first preparation liquid; s3, weighing trehalose, astaxanthin, glycerol, adenosine, acetyl hexapeptide-8, fullerene, xanthan gum and carnosine, adding into the first transparent solution, and stirring and heating to obtain a second transparent solution; and S4, filling the transparent preparation liquid II into a penicillin bottle, covering a bottle stopper, putting the penicillin bottle into freeze-drying equipment, and freeze-drying. The invention has the advantages that: can effectively whiten, lighten spots, prevent sunburn, remove free radicals in skin and delay skin aging, has no side effect and is convenient to use.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to astaxanthin essence extract freeze-dried powder and a preparation method thereof.
Background
The modern social life of matters is more and more abundant, people also pay more and more attention to the personal appearance problem, the sun light is strongly irradiated in summer, and the ultraviolet radiation is enhanced, so that the skin is blackened and burnt; meanwhile, with the increase of age and the deterioration of living environment, the metabolism of the skin is reduced, the function of absorbing various beneficial elements is reduced, water is easy to lose, various harmful substances are easy to stay on the surface of the skin, and the skin gradually loses the original elasticity, so that the skin is aged. Nowadays, skin care products become the most popular choice for most people, especially for contemporary women, and good skin care products can play roles in promoting skin blood circulation, repairing skin injury, removing wrinkles, increasing skin elasticity and luster, caring sensitive skin, and the like.
However, although skin care products on the market are full of various types, most skin care products are fine chemical products, only the surface layer problem of the skin is solved, the effects of repairing the skin and delaying skin aging cannot be fundamentally achieved, and some cosmetics are added with components such as hormone, the beauty effect is not obvious, the negative influence is caused on the human body, and the use safety performance is poor.
Disclosure of Invention
The invention aims to solve the technical problems and provides the sea cucumber intestine egg essence extract freeze-dried powder which can effectively whiten, lighten spots, prevent sunburn, remove free radicals in skin and delay skin aging, has no side effect and is convenient to use and a preparation method thereof.
In order to solve the technical problems, the technical scheme provided by the invention is as follows: an astaxanthin essence extract freeze-dried powder comprises the following components in percentage by mass: 4 to 5 percent of mannitol, 3 to 4 percent of trehalose, 1.5 to 2.5 percent of astaxanthin, 0.5 to 1.5 percent of glycerol, 0.03 to 0.07 percent of adenosine, 81.5 to 2.5 percent of acetyl hexapeptide, 0.01 to 0.05 percent of fullerene, 0.03 to 0.07 percent of xanthan gum, 0.03 to 0.07 percent of carnosine, 0.5 to 1.5 percent of hyaluronic acid and 85 to 86 percent of water.
Preferably, the composition comprises the following components in percentage by mass: 4.2 to 4.8 percent of mannitol, 3.2 to 3.8 percent of trehalose, 1.7 to 2.3 percent of astaxanthin, 0.7 to 1.3 percent of glycerol, 0.04 to 0.06 percent of adenosine, 81.7 to 2.3 percent of acetyl hexapeptide, 0.02 to 0.04 percent of fullerene, 0.04 to 0.06 percent of xanthan gum, 0.04 to 0.06 percent of carnosine, 0.7 to 1.3 percent of hyaluronic acid and 85.2 to 85.9 percent of water.
Preferably, the composition comprises the following components in percentage by mass: 4.5% of mannitol, 3.5% of trehalose, 2% of astaxanthin, 1% of glycerol, 0.05% of adenosine, 0.82% of acetyl hexapeptide, 0.03% of fullerene, 0.05% of xanthan gum, 0.05% of carnosine, 1% of hyaluronic acid and 85.82% of water.
Preferably, the water is purified water after secondary filtration.
Preferably, the preparation method of the astaxanthin essence extract freeze-dried powder comprises the following steps:
s1, weighing hyaluronic acid, mannitol and water, stirring for 12-30 minutes, heating to 70-80 ℃ to obtain a first transparent preparation solution;
s2, cooling the transparent first preparation solution to enable the transparent first preparation solution to be cooled to 15-30 ℃ at a constant speed;
s3, weighing trehalose, astaxanthin, glycerol, adenosine, acetyl hexapeptide-8, fullerene, xanthan gum and carnosine, adding the weighed materials into the first transparent solution, stirring for 15-30 minutes, heating at the temperature of 40-60 ℃ to obtain a second transparent solution;
s4, filling the transparent preparation liquid II into a penicillin bottle, covering a bottle stopper, putting the penicillin bottle into a freeze-drying device, and freeze-drying at the temperature of-15 to-5 ℃.
Compared with the prior art, the invention has the advantages that: according to the astaxanthin essence extract freeze-dried powder and the preparation method thereof, trehalose can form a unique protective film on the cell surface under severe environmental conditions such as high temperature, high cold, high osmotic pressure, drying and dehydration and the like, so that protein molecules can be effectively protected from inactivation without denaturation, and skin cells can be well protected; acetyl hexapeptide-8 is a bioactive polypeptide, can locally block nerve transmission muscle contraction information, influence skin sac nerve conduction, relax facial muscles, smooth dynamic lines, static lines and fine lines, effectively reorganize collagen elasticity, increase elastin activity, relax facial lines, smooth wrinkles and improve skin relaxation; the fullerene has strong oxidation resistance, and can play a role in activating skin cells and preventing skin decay; the xanthan gum can supplement moisture to the skin, prevent moisture loss, prevent wrinkles of the skin and resist aging; astaxanthin has effects of resisting oxidation, resisting aging, scavenging oxygen free radicals, whitening skin, removing speckle, preventing sunburn, and relieving skin dullness and melanin pigmentation; glycerin can keep skin moist; carnosine can prevent skin aging and whiten skin, and can prevent free radicals generated by smoking and protect skin; meanwhile, the freeze-drying synthesis process is adopted to fully extract the effective components in the raw materials, so that the freeze-drying powder is smeared on the face when in use, and the face mask is convenient to use and good in absorptivity.
Detailed Description
Example one
An astaxanthin essence extract freeze-dried powder comprises the following components in percentage by mass: 4.3% of mannitol, 3.7% of trehalose, 1.8% of astaxanthin, 1.2% of glycerol, 0.04% of adenosine, 81.8% of acetyl hexapeptide, 0.04% of fullerene, 0.04% of xanthan gum, 0.06% of carnosine, 1.15% of hyaluronic acid and 85.87% of water.
The preparation method comprises the following steps:
s1, weighing hyaluronic acid, mannitol and water, stirring for 20 minutes, heating to 80 ℃ to obtain a first transparent preparation solution;
s2, cooling the transparent first preparation solution to enable the temperature to be reduced to 25 ℃ at a constant speed;
s3, weighing trehalose, astaxanthin, glycerol, adenosine, acetyl hexapeptide-8, fullerene, xanthan gum and carnosine, adding the weighed materials into the first transparent solution, stirring for 30 minutes, heating to the temperature of 60 ℃ to obtain a second transparent solution;
s4, filling the transparent preparation liquid II into a penicillin bottle, covering a bottle stopper, putting the penicillin bottle into freeze-drying equipment, and freeze-drying at the temperature of-5 ℃.
Example two
An astaxanthin essence extract freeze-dried powder comprises the following components in percentage by mass: 4.5% of mannitol, 3.5% of trehalose, 2% of astaxanthin, 1% of glycerol, 0.05% of adenosine, 0.82% of acetyl hexapeptide, 0.03% of fullerene, 0.05% of xanthan gum, 0.05% of carnosine, 1% of hyaluronic acid and 85.82% of water.
The preparation method comprises the following steps:
s1, weighing hyaluronic acid, mannitol and water, stirring for 25 minutes, heating to 75 ℃ to obtain a first transparent preparation solution;
s2, cooling the transparent first preparation solution to ensure that the temperature is reduced to 22 ℃ at a constant speed;
s3, weighing trehalose, astaxanthin, glycerol, adenosine, acetyl hexapeptide-8, fullerene, xanthan gum and carnosine, adding the weighed materials into the first transparent solution, stirring for 25 minutes, heating to 50 ℃ to obtain a second transparent solution;
s4, filling the transparent preparation liquid II into a penicillin bottle, covering a bottle stopper, putting the penicillin bottle into freeze-drying equipment, and freeze-drying at the temperature of-12 ℃.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Claims (5)
1. The astaxanthin essence extract freeze-dried powder is characterized by comprising the following components in percentage by mass: 4 to 5 percent of mannitol, 3 to 4 percent of trehalose, 1.5 to 2.5 percent of astaxanthin, 0.5 to 1.5 percent of glycerol, 0.03 to 0.07 percent of adenosine, 81.5 to 2.5 percent of acetyl hexapeptide, 0.01 to 0.05 percent of fullerene, 0.03 to 0.07 percent of xanthan gum, 0.03 to 0.07 percent of carnosine, 0.5 to 1.5 percent of hyaluronic acid and 85 to 86 percent of water.
2. The astaxanthin essence extract freeze-dried powder according to claim 1, which is characterized by comprising the following components in percentage by mass: 4.2 to 4.8 percent of mannitol, 3.2 to 3.8 percent of trehalose, 1.7 to 2.3 percent of astaxanthin, 0.7 to 1.3 percent of glycerol, 0.04 to 0.06 percent of adenosine, 81.7 to 2.3 percent of acetyl hexapeptide, 0.02 to 0.04 percent of fullerene, 0.04 to 0.06 percent of xanthan gum, 0.04 to 0.06 percent of carnosine, 0.7 to 1.3 percent of hyaluronic acid and 85.2 to 85.9 percent of water.
3. The astaxanthin essence extract freeze-dried powder according to claim 1, which is characterized by comprising the following components in percentage by mass: 4.5% of mannitol, 3.5% of trehalose, 2% of astaxanthin, 1% of glycerol, 0.05% of adenosine, 0.82% of acetyl hexapeptide, 0.03% of fullerene, 0.05% of xanthan gum, 0.05% of carnosine, 1% of hyaluronic acid and 85.82% of water.
4. The astaxanthin essence extract freeze-dried powder according to claim 1, characterized in that: the water is purified water after secondary filtration.
5. The preparation method of the astaxanthin essence extract freeze-dried powder according to claim 1, which is characterized by comprising the following steps of:
s1, weighing hyaluronic acid, mannitol and water, stirring for 12-30 minutes, heating to 70-80 ℃ to obtain a first transparent preparation solution;
s2, cooling the transparent first preparation solution to enable the transparent first preparation solution to be cooled to 15-30 ℃ at a constant speed;
s3, weighing trehalose, astaxanthin, glycerol, adenosine, acetyl hexapeptide-8, fullerene, xanthan gum and carnosine, adding the weighed materials into the first transparent solution, stirring for 15-30 minutes, heating at the temperature of 40-60 ℃ to obtain a second transparent solution;
s4, filling the transparent preparation liquid II into a penicillin bottle, covering a bottle stopper, putting the penicillin bottle into a freeze-drying device, and freeze-drying at the temperature of-15 to-5 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911255525.9A CN110876707A (en) | 2019-12-10 | 2019-12-10 | Astaxanthin essence extract freeze-dried powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911255525.9A CN110876707A (en) | 2019-12-10 | 2019-12-10 | Astaxanthin essence extract freeze-dried powder and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110876707A true CN110876707A (en) | 2020-03-13 |
Family
ID=69731023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911255525.9A Withdrawn CN110876707A (en) | 2019-12-10 | 2019-12-10 | Astaxanthin essence extract freeze-dried powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110876707A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111358732A (en) * | 2020-04-08 | 2020-07-03 | 陈占军 | Rice fermentation product and rice bran extract freeze-dried powder and preparation method thereof |
CN111419734A (en) * | 2020-05-14 | 2020-07-17 | 华熙生物科技股份有限公司 | Composition for improving astaxanthin transdermal absorption and application thereof |
-
2019
- 2019-12-10 CN CN201911255525.9A patent/CN110876707A/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111358732A (en) * | 2020-04-08 | 2020-07-03 | 陈占军 | Rice fermentation product and rice bran extract freeze-dried powder and preparation method thereof |
CN111419734A (en) * | 2020-05-14 | 2020-07-17 | 华熙生物科技股份有限公司 | Composition for improving astaxanthin transdermal absorption and application thereof |
CN111419734B (en) * | 2020-05-14 | 2022-07-22 | 华熙生物科技股份有限公司 | Composition for improving transdermal absorption of astaxanthin and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102302417B (en) | Comprehensive-effect sunscreen lotion containing oceanic biological active substances | |
CN109106664A (en) | Have effects that moisturizing is releived the composition of maintenance, facial mask and preparation method thereof | |
CN110772449A (en) | Skin rejuvenation freeze-dried powder and preparation method thereof | |
CN105147556A (en) | Stromal cell activation factor essence | |
CN111700833A (en) | Facial cream for repairing plateau red skin and preparation method and application thereof | |
CN110876707A (en) | Astaxanthin essence extract freeze-dried powder and preparation method thereof | |
CN110840775A (en) | Anti-wrinkle firming freeze-dried powder and preparation method thereof | |
CN111840124A (en) | Oligopeptide water-sensitive skin beautifying mask, essence thereof and preparation method of essence | |
CN111904897A (en) | Nourishing type lip cosmetic and preparation method thereof | |
CN110755332A (en) | Essence capable of replenishing water, whitening skin and removing freckles and preparation method of essence | |
CN110755348A (en) | Skin care composition and preparation method thereof | |
CN113576975A (en) | Easily-absorbed anti-aging composition and preparation method and application thereof | |
CN114259419B (en) | Compound composition containing recombinant collagen and preparation method and application thereof | |
CN110559226A (en) | Whitening lotion and preparation method thereof | |
CN109700750A (en) | A kind of anti-ageing face mask and preparation method thereof containing sodium hyaluronate | |
CN111759762A (en) | Black eye removing composition, essence and preparation method thereof | |
CN112353703A (en) | Nourishing and skin-tendering night cream | |
CN112933029A (en) | Sea cucumber intestine and egg essence extract freeze-dried powder and preparation method thereof | |
CN111067860A (en) | Stem cell secretion factor mask for whitening skin and fading acne marks and preparation method thereof | |
CN112587468A (en) | Multifunctional multiple-effect eye cream | |
CN106491477A (en) | A kind of skin care item and preparation method thereof | |
KR101077693B1 (en) | Cosmetic composition containing xylitol and β-1,3-glucane for moisturizing effect on the skin | |
CN112402325A (en) | Safflower polypeptide reverse-aging cream | |
CN110876683A (en) | Blue copper polypeptide freeze-dried powder and preparation method thereof | |
CN111481476A (en) | Potato facial mask with multiple skin care effects and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200313 |